2YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
Amuvatinib;MP470 | N-(1,3-苯并二氧戊环-5-基甲基)-4-苯并呋喃并[3,2-D]嘧啶-4-基-1-哌嗪硫代甲酰胺 | 850879-09-3 |
BTZ043 | 2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮 | 1161233-85-7 |
BMS-794833 | BMS-794833 | 1174046-72-0 |
Alvelestat (AZD9668) | ALVELESTAT | 848141-11-7 |
PTC-209 | PTC-209 | 315704-66-6 |
MLN1117,INK1117 | [6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮 | 1268454-23-4 |
C-DIM12 | C-DIM12 | 178946-89-9 |
T0901317 | N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]苯磺酰胺 | 293754-55-9 |
Tiplaxtinin(PAI-039) | 替普沙汀 | 393105-53-8 |
SB505124 | SB-505124 | 694433-59-5 |
LY 294002 | LY294002/PI3K抑制剂 | 154447-36-6 |
IC-87114 | 2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 | 371242-69-2 |
RO4929097 | N1-[(7S)-6,7-二氢-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]-2,2-二甲基-N3-(2,2,3,3,3-五氟丙基)丙二酰胺 | 847925-91-1 |
STF-31 | 4-((4-(叔丁基)苯基磺酰胺基)甲基)-N-(吡啶-3-基)苯甲酰胺 | 724741-75-7 |
KN-93 hydrochloride | 化合物 T21557 | 1956426-56-4 |
PFI 4;PFI-4 | N-(1,3-二甲基-2-氧代-6-(吡咯烷-1-基)-2,3-二氢-1H-苯并[D]咪唑-5-基)-2-甲氧基苯甲酰胺 | 900305-37-5 |
Akti-1/2 | 1,3-二氢-1-[1-[[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基]甲基]-4-哌啶基]-2H-苯并咪唑-2-酮 | 612847-09-3 |
SB 203580 | 4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑 | 152121-47-6 |
WAY-362450;XL335 | 3-(3,4-二氟苯甲酰基)-1,2,3,6-四氢-1,1-二甲基氮杂卓[4,5-B]吲哚-5-甲酸 1-甲基乙基酯 | 629664-81-9 |
WHI-P154 | 2-溴-4-(6,7-二甲氧基喹唑啉-4-基氨基)苯酚 | 211555-04-3 |
NVP-BEP800 | NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE | 847559-80-2 |
PF-4708671 | PF-4708671 | 1255517-76-0 |
Bikinin | Bikinin | 188011-69-0 |
LXR623 | 2-[(2-氯-4-氟苯基)甲基]-3-(4-氟苯基)-7-(三氟甲基)-2H-吲唑 | 875787-07-8 |
BMS-582949 | BMS 582949 | 623152-17-0 |
Remodelin HBr | REMODELIN | 1622921-15-6 |
SP2509 | SP2509 | 1423715-09-6 |
SR9243 | N-[2-(3-溴苯基)乙基]-2,4,6-三甲基-N-[[3'-(甲基磺酰基)[1,1'-联苯]-4-基]甲基]苯磺酰胺 | 1613028-81-1 |
PD-1/PD-L1 inhibitor 1 | PD-1 | 1675201-83-8 |
Varespladib (LY315920) | 伐瑞拉迪 | 172732-68-2 |
Losmapimod;GW856553X | Losmapimod (GW856553X) | 585543-15-3 |
PKI-587;Gedatolisib | N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-吗啉基)-1,3,5-三嗪-2-基]苯基]脲 | 1197160-78-3 |
IOX2 | IOX 2 | 931398-72-0 |
XL019 | XL019 | 945755-56-6 |
PND-1186,SR-2156 | PND1186 | 1061353-68-1 |
Radotinib;IY5511 | 拉多替尼 | 926037-48-1 |
AZD2858 | AZD2858 | 486424-20-8 |
WH-4-023 | 2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE | 837422-57-8 |
GSK591 (EPZ-015866) | GSK591 (EPZ-015866) | 1616391-87-7 |
AMI-1 | 猩红酸钠盐 | 20324-87-2 |
GNF-7 | GNF-7 | 839706-07-9 |
AGI-6780 | AGI-6780 | 1432660-47-3 |
RKI-1447 | 1-(3-羟基苄基)-3-(4-(吡啶-4-基)噻唑-2-基)脲 | 1342278-01-6 |
4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide | BLZ945 | 953769-46-5 |
Epacadostat (INCB024360) | 艾卡哚司他 | 1204669-58-8 |
OICR-9429 | OICR-9429 | 1801787-56-3 |
BI 9564 | 化合物BI9564 | 1883429-22-8 |
MX-69 | MX69 | 1005264-47-0 |
PF-CBP1 HCl | 化合物PF-CBP1 | 1962928-21-7 |
ly2784544 | LY 2784544 | 1229236-86-5 |
NVP-LDE225 | 索尼吉布 | 956697-53-3 |
SC-202671 | SC-202671 | 312917-14-9 |
VGX-1027 | 4,5-DIHYDRO-3-PHENYL-5-ISOXAZOLEACETICACID | 6501-72-0 |
RVX-208 | RVX-208 | 1044870-39-4 |
AGI5198 | AGI-5198 (IDH-C35) | 1355326-35-0 |
Napabucasin (BBI608) | 2-乙酰基呋喃并-1,4-萘醌 | 83280-65-3 |
MK-8745 | MK8745 | 885325-71-3 |
GSK2801 | GSK2801 | 1619994-68-1 |
LY2584702 tosylate salt | LY2584702 TOSYLATE | 1082949-68-5 |
PF-06447475 | PF-06447475 | 1527473-33-1 |
RBC8 | RBC8 | 361185-42-4 |
Enasidenib | 恩西地平 | 1446502-11-9 |
DMXAA | 2,5-己酮可可碱 | 117570-53-3 |
CI-994(Tacedinaline) | 4-乙酰氨基-N-(2'-氨基苯基)-苯甲酰胺 | 112522-64-2 |
RO 61-8048 | RO 61-8048 | 199666-03-0 |
GSK1059615 | (5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 | 958852-01-2 |
C646 | C646 | 328968-36-1 |
PRX-08066 | PRX-08066 | 866206-54-4 |
StemRegenin 1 (SR1) | SR-1;SR1 | 1227633-49-9 |
ABT-199 | ABT-199 | 1257044-40-8 |
Necrosulfonamide | N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺 | 1360614-48-7 |
GKT137831 | 2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮 | 1218942-37-0 |
TP-0903 | TP-0903 | 1341200-45-0 |
MK-4101 | 5-(3,3-二氟环丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]双环[2.2.2]辛烷-1-基]-1,2,4-恶二唑 | 935273-79-3 |
GSK583 | 6-(叔丁基磺酰基)-N-(5-氟-1H-吲唑-3-基)喹啉-4-胺 | 1346547-00-9 |
Necrostatin-1 | NECROSTATIN-1 | 4311-88-0 |
BMS-707035 | N-[(4-氟苯基)甲基1,6-二氢-5-羟基-1-甲基-6-氧代-2-(四氢-1,1-二氧-2H-1,2-噻嗪-2-基)-4-嘧啶甲酰胺 | 729607-74-3 |
ADX 47273 | (S)-(4-氟苯基)-{3-[3-(4-氟苯基)-[1,2,4]二唑-5-基]哌啶-1-基}甲酮 | 851881-60-2 |
AZD1080 | AZD1080 | 612487-72-6 |
GSK503 | 化合物GSK503 | 1346572-63-1 |
ABT-751;E7010 | N-[2-[(4-羟基苯基)氨基]-3-吡啶基]-4-甲氧基苯磺酰胺 | 141430-65-1 |
TG-101209 | N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 | 936091-14-4 |
XAV-939 | 3,5,7,8-四氢-2-[4-(三氟甲基)苯基]-4H-噻喃并[4,3-D]嘧啶-4-酮 | 284028-89-3 |
STF-62247 | N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺 | 315702-99-9 |
KN-92 hydrochloride | KN-92 盐酸盐 | 1431698-47-3 |
AdipoRon | 阿迪普隆 | 924416-43-3 |
BQU57 | BQU57 | 1637739-82-2 |
CZ415 | CZ415 | 1429639-50-8 |
SCH 58261 | SCH58261 | 160098-96-4 |
MI 2 (MALT1 inhibitor) | 2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺 | 1047953-91-2 |
BMS-863233;XL413 (hydrochloride) | XL413 (BMS-863233) | 1169562-71-3 |
GSK2578215A | 5-(2-氟-4-吡啶基)-2-(苯基甲氧基)-N-3-吡啶基苯甲酰胺 | 1285515-21-0 |
U-104;NSC-213841 | U-104 | 178606-66-1 |
KY02111 | KY 02111 | 1118807-13-8 |
Merestinib | 梅沙替尼 | 1206799-15-6 |
CCT007093 | (2E,5E)-2,5-二(2-噻吩基亚甲基)环戊酮 | 176957-55-4 |
Ceralasertib | AZD6738 | 1352226-88-0 |
HA15 | HA-15 | 1609402-14-3 |
WY-14643 (Pirinixic Acid) | 匹立尼酸 | 50892-23-4 |
BAY11-7082 | (E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE | 19542-67-7 |
联系方式